PubRank

Elvira Grandone

Author PubWeight™ 71.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012 10.64
2 Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010 6.90
3 Authors' response to the letter of Nagirnaja et al., "Response to annexin A5 haplotype M2 is not a risk factor for recurrent miscarriages in Northern Europe, is there sufficient evidence?". Reprod Biomed Online 2016 4.98
4 A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood 2004 4.70
5 Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011 3.68
6 Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology 2007 2.32
7 Thrombophilic mutations are a main risk factor for placental abruption. Haematologica 2003 1.65
8 Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics. Liver Int 2005 1.63
9 Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004 1.62
10 Clinical relevance of inherited thrombophilia in implantation failure: who needs to be screened? Haematologica 2003 1.42
11 Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007 1.13
12 Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin. Haematologica 2004 1.12
13 Impact of prothrombotic mutations and family history on the occurrence of intra-uterine fetal deaths. Haematologica 2002 0.99
14 Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease. Pharmacogenet Genomics 2011 0.95
15 The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica 2008 0.91
16 Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications. Thromb Haemost 2009 0.91
17 Population genetics of venous thromboembolism. A narrative review. Thromb Haemost 2010 0.91
18 Clinical utility of screening for CALR gene exon 9 mutations in patients with splanchnic venous thrombosis. Thromb Haemost 2015 0.89
19 Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 2008 0.89
20 Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors. Eur J Obstet Gynecol Reprod Biol 2004 0.86
21 Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost 2002 0.86
22 PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant 2003 0.85
23 Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome. Blood Coagul Fibrinolysis 2008 0.85
24 Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2. Fertil Steril 2008 0.84
25 A novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defect in Wolfram syndrome type 2. BMC Med Genet 2014 0.83
26 Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis. Thromb Res 2011 0.83
27 Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009 0.83
28 The C677T methylenetetrahydrofolate reductase gene mutation does not influence cardiovascular risk in the dialysis population: results of a multicentre prospective study. Nephrol Dial Transplant 2004 0.83
29 TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings. Biomed Res Int 2013 0.82
30 Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group. Blood Coagul Fibrinolysis 2006 0.82
31 Symptomatic venous thromboembolism and thrombophilic status in adult acute leukemia: a single-center experience of 114 patients at diagnosis. Acta Haematol 2007 0.81
32 The haplotype M2 within the ANXA5 gene is independently associated with the occurrence of deep venous thrombosis. Thromb Haemost 2010 0.81
33 A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis. Blood 2007 0.81
34 Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation. Thromb Res 2013 0.81
35 Homozygosity by descent of a 3Mb chromosome 17 haplotype causes coinheritance of Glanzmann thrombasthenia and primary ciliary dyskinesia. Blood 2013 0.79
36 Fatal pulmonary thromboembolism. A retrospective autopsy study: searching for genetic thrombophilias (Factor V Leiden (G1691A) and FII (G20210A) gene variants) and dating the thrombus. Forensic Sci Int 2011 0.79
37 Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet 2007 0.78
38 A new method for determination of plasma homocystine by isotope dilution and electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006 0.78
39 FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile. Thromb Haemost 2002 0.77
40 Deep venous thrombosis in elderly hospitalized patients: prevalence and clinical features. Aging Clin Exp Res 2005 0.77
41 Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus. Thromb Haemost 2006 0.77
42 A rapid method for the quantification of the enantiomers of Warfarin, Phenprocoumon and Acenocoumarol by two-dimensional-enantioselective liquid chromatography/electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007 0.77
43 Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant. J Pharm Biomed Anal 2013 0.77
44 Fetal sex identification in maternal plasma by means of short tandem repeats on chromosome x. Ann N Y Acad Sci 2008 0.76
45 Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses. Ann Hematol 2013 0.76
46 Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: impairment of mechanisms involved in maintaining intervillous blood flow. Thromb Res 2009 0.76
47 Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation. Thromb Haemost 2008 0.76
48 Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta. Thromb Res 2008 0.75
49 Maternal and fetal inherited thrombophilias. Am J Obstet Gynecol 2002 0.75
50 Thrombophilia polymorphisms and intrauterine growth restriction. N Engl J Med 2002 0.75
51 Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection. Eur J Epidemiol 2007 0.75
52 Influence of the Gly1057Asp variant of the insulin receptor substrate 2 (IRS2) on insulin resistance and relationship with epicardial fat thickness in the elderly. Exp Gerontol 2012 0.75
53 A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions. Blood Coagul Fibrinolysis 2008 0.75
54 Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domain. Haematologica 2004 0.75
55 A reliable and rapid tool for plasma quantification of 18 psychotropic drugs by ESI tandem mass spectrometry. J Pharm Biomed Anal 2012 0.75
56 Effects of ethylene oxide and steam sterilization on dialysis-induced cytokine release by cuprophan membrane. Artif Organs 2002 0.75
57 Postpartum haemorrhage in a woman with essential thrombocythemia carrying calreticulin mutation: a case report. Blood Coagul Fibrinolysis 2016 0.75
58 Setting up a 2D-LC/MS/MS method for the rapid quantitation of the prostanoid metabolites 6-oxo-PGF(1alpha) and TXB2 as markers for hemostasis assessment. J Mass Spectrom 2009 0.75
59 The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation. Haematologica 2003 0.75
60 Stable-isotope dilution LC-ESI-MS/MS techniques for the quantification of total homocysteine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2009 0.75
61 Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation. Thromb Haemost 2012 0.75
62 Influence of hCG on inducible nitric oxide synthase gene expression in ram testicular arteries. Arch Ital Urol Androl 2014 0.75
63 A platelet defect modulates bleeding in mild hemophilia: the tale of 2 brothers. Clin Appl Thromb Hemost 2009 0.75
64 Expression and hormonal modulation of the thromboxane A2 receptor gene in mammalian testicular arteries. Fertil Steril 2006 0.75